ArticleACS infectious diseases2022

Human Kinase IGF1R/IR Inhibitor Linsitinib Controls the In Vitro and Intracellular Growth of

Heng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.